ANN ARBOR, Mich. & PHILADELPHIA--(BUSINESS WIRE)--SensiGen LLC, a biotechnology company focused on developing advanced gene-based molecular diagnostics, announced today that Dr. Nicholas A. Kefalides has joined the company’s Scientific Advisory Board. Dr. Kefalides is a world renowned expert on the role of connective tissues and basement membranes in degenerative and infectious diseases and cancers, a unique and specialized area of study that sits at the core of the scientific community’s efforts to identify and detect unique biomarkers that are the harbingers of a great majority of the world’s most prevalent diseases.
